An established, collaborative, global cell therapy CDMO.
Reduce timelines and costs. De-risk clinical trials. Get to patients faster.
Download BioCentriq's new eBook!
Five chapters of actionable advice on how to ensure quality, improve patient access, and reduce the cost of manufacturing.
Learn how to assess GMP-readiness and save time and money.
An Established, Collaborative, Global Cell Therapy CDMO
BioCentriq is a full-service, collaborative cell therapy CDMO. We support all stages of process development and cell therapy manufacturing.
What sets us apart from other CDMOs is our approach which is highly collaborative, transparent and attentive.
From the very beginning, you and your team are invited on site and given the option to work alongside our team.
Our established, phase appropriate quality systems and newly constructed facilities are uniquely designed to support the needs of early-stage autologous and allogeneic drug products.
Importantly, we also have a track record of successfully manufacturing and releasing drug products for use in human trials.
Are you advancing a product to clinic? Learn how you can get there faster with our proprietary LEAPTM Advanced Therapy Platform which helps early-stage developers go from contract to clinic in as short as six months.
Get to know BioCentriq and experience the innovative, open, collaborative, highly attentive and pragmatic approach we bring to every project.
Why BioCentriq
Phase-Appropriate Established Quality Systems
LEAPTM Platform for NK, CAR/TCR, T-Cell and Exosome Candidates
Access to Novel Development and Manufacturing Technologies
Latest Updates
Upcoming Events
Join Our Team
We are looking for passionate and driven individuals with a background in cell therapy to join our growing team. If you thrive in a fast-paced, always evolving environment and embrace the mission of making cell therapies accessible to the patients who need them, we want to hear from you! Please browse our current job listings or contact our HR team.